Literature DB >> 19745221

Screening for colorectal cancer in a safety-net health care system: access to care is critical and has implications for screening policy.

Samir Gupta1, Liyue Tong, James E Allison, Elizabeth Carter, Mark Koch, Don C Rockey, Paula Anderson, Chul Ahn, Keith Argenbright, Celette Sugg Skinner.   

Abstract

BACKGROUND: Data on the number of individuals eligible for screening, and rates of screening, are necessary to assess national colorectal cancer screening efforts. Such data are sparse for safety-net health systems.
METHODS: A retrospective cohort study of individuals ages 50 to 75 served by a safety-net health system in Tarrant County, TX was conducted to determine (a) the size of the potential screen-eligible population ages 50 to 75, (b) the rate of screening over 5 years among individuals ages 54 to 75, and (c) the potential predictors of screening, including sex, race/ethnicity, insurance status, frequency of outpatient visits, and socioeconomic status.
RESULTS: Of 28,708 potential screen-eligible individuals, 20,416 were ages 54 to 75 and analyzed for screening; 22.0% were screened within the preceding 5 years. Female gender, Hispanic ethnicity, ages 65 to 75, insurance status, and two or more outpatient visits were independently associated with screening. Access to care was an important factor: adjusted odds ratio, 2.57 (95% confidence interval, 2.23-2.98) for any insurance; adjusted odds ratio, 3.53 (95% confidence interval, 3.15-3.97) for two or more outpatient visits.
CONCLUSIONS: The screen-eligible population served by our safety-net health system was large, and the projected deficit in screen rates was substantial. Access to care was the dominant predictor of screening participation. If our results are replicable in similar health systems, the data suggest that screening guidelines and policy efforts must take into account the feasibility of proposed interventions. Strong advocacy for more resources for colorectal cancer screening interventions (including research into the best manner to provide screening for large populations) is needed.

Entities:  

Mesh:

Year:  2009        PMID: 19745221      PMCID: PMC2767330          DOI: 10.1158/1055-9965.EPI-09-0344

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  24 in total

Review 1.  Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter?: the Public Health Disparities Geocoding Project.

Authors:  Nancy Krieger; Jarvis T Chen; Pamela D Waterman; Mah-Jabeen Soobader; S V Subramanian; Rosa Carson
Journal:  Am J Epidemiol       Date:  2002-09-01       Impact factor: 4.897

2.  Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study.

Authors:  Jean Faivre; Vincent Dancourt; Catherine Lejeune; Mohamed A Tazi; Joseph Lamour; Dominique Gerard; Frederic Dassonville; Claire Bonithon-Kopp
Journal:  Gastroenterology       Date:  2004-06       Impact factor: 22.682

3.  Revisiting the behavioral model and access to medical care: does it matter?

Authors:  R M Andersen
Journal:  J Health Soc Behav       Date:  1995-03

4.  Randomised, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107,349 subjects.

Authors:  J D Hardcastle; W M Thomas; J Chamberlain; G Pye; J Sheffield; P D James; T W Balfour; S S Amar; N C Armitage; S M Moss
Journal:  Lancet       Date:  1989-05-27       Impact factor: 79.321

5.  Racial differences in mortality among men hospitalized in the Veterans Affairs health care system.

Authors:  A K Jha; M G Shlipak; W Hosmer; C D Frances; W S Browner
Journal:  JAMA       Date:  2001-01-17       Impact factor: 56.272

6.  Randomised study of screening for colorectal cancer with faecal-occult-blood test.

Authors:  O Kronborg; C Fenger; J Olsen; O D Jørgensen; O Søndergaard
Journal:  Lancet       Date:  1996-11-30       Impact factor: 79.321

7.  Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study.

Authors:  J S Mandel; J H Bond; T R Church; D C Snover; G M Bradley; L M Schuman; F Ederer
Journal:  N Engl J Med       Date:  1993-05-13       Impact factor: 91.245

8.  Having a personal health care provider and receipt of colorectal cancer testing.

Authors:  Roberto Cardarelli; Jennifer E Thomas
Journal:  Ann Fam Med       Date:  2009 Jan-Feb       Impact factor: 5.166

9.  Zip code caveat: bias due to spatiotemporal mismatches between zip codes and US census-defined geographic areas--the Public Health Disparities Geocoding Project.

Authors:  Nancy Krieger; Pamela Waterman; Jarvis T Chen; Mah-Jabeen Soobader; S V Subramanian; Rosa Carson
Journal:  Am J Public Health       Date:  2002-07       Impact factor: 9.308

10.  Survival of colorectal cancer patients hospitalized in the Veterans Affairs Health Care System.

Authors:  Linda Rabeneck; Julianne Souchek; Hashem B El-Serag
Journal:  Am J Gastroenterol       Date:  2003-05       Impact factor: 10.864

View more
  16 in total

Review 1.  Challenges and possible solutions to colorectal cancer screening for the underserved.

Authors:  Samir Gupta; Daniel A Sussman; Chyke A Doubeni; Daniel S Anderson; Lukejohn Day; Amar R Deshpande; B Joseph Elmunzer; Adeyinka O Laiyemo; Jeanette Mendez; Ma Somsouk; James Allison; Taft Bhuket; Zhuo Geng; Beverly B Green; Steven H Itzkowitz; Maria Elena Martinez
Journal:  J Natl Cancer Inst       Date:  2014-03-28       Impact factor: 13.506

2.  Inadequate Utilization of Diagnostic Colonoscopy Following Abnormal FIT Results in an Integrated Safety-Net System.

Authors:  Rachel B Issaka; Maneesh H Singh; Sachiko M Oshima; Victoria J Laleau; Carly D Rachocki; Ellen H Chen; Lukejohn W Day; Urmimala Sarkar; Ma Somsouk
Journal:  Am J Gastroenterol       Date:  2016-12-13       Impact factor: 10.864

3.  Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach.

Authors:  Ethan A Halm; Elisabeth F Beaber; Dale McLerran; Jessica Chubak; Douglas A Corley; Carolyn M Rutter; Chyke A Doubeni; Jennifer S Haas; Bijal A Balasubramanian
Journal:  J Gen Intern Med       Date:  2016-06-08       Impact factor: 5.128

4.  Measurement of colorectal cancer test use with medical claims data in a safety-net health system.

Authors:  Samir Gupta; Liyue Tong; Paula Anderson; Bonnie Rose; Elizabeth Carter; Mark Koch; Keith Argenbright; Chul Ahn; James Allison; Celette Sugg Skinner
Journal:  Am J Med Sci       Date:  2013-02       Impact factor: 2.378

Review 5.  Use of NCCN Guidelines, Other Guidelines, and Biomarkers for Colorectal Cancer Screening.

Authors:  Christina D Williams; William M Grady; Leah L Zullig
Journal:  J Natl Compr Canc Netw       Date:  2016-11       Impact factor: 11.908

6.  Self-reported barriers to colorectal cancer screening in a racially diverse, low-income study population.

Authors:  Benjamin W Quick; Christina M Hester; Kristin L Young; K Allen Greiner
Journal:  J Community Health       Date:  2013-04

7.  Reasons for Lack of Diagnostic Colonoscopy After Positive Result on Fecal Immunochemical Test in a Safety-Net Health System.

Authors:  Jason Martin; Ethan A Halm; Jasmin A Tiro; Zahra Merchant; Bijal A Balasubramanian; Katharine McCallister; Joanne M Sanders; Chul Ahn; Wendy Pechero Bishop; Amit G Singal
Journal:  Am J Med       Date:  2016-08-31       Impact factor: 4.965

8.  Economic assessment of patient navigation to colonoscopy-based colorectal cancer screening in the real-world setting at the University of Chicago Medical Center.

Authors:  Karen E Kim; Fornessa Randal; Matt Johnson; Michael Quinn; Chieko Maene; Sonja Hoover; Valerie Richmond-Reese; Florence K L Tangka; Djenaba A Joseph; Sujha Subramanian
Journal:  Cancer       Date:  2018-10-25       Impact factor: 6.860

9.  Late presentation of colorectal cancer in a vulnerable population.

Authors:  Chanda Ho; Rachel Kornfield; Eric Vittinghoff; John Inadomi; Hal Yee; Ma Somsouk
Journal:  Am J Gastroenterol       Date:  2013-04       Impact factor: 10.864

10.  Financial Incentives to Promote Colorectal Cancer Screening: A Longitudinal Randomized Control Trial.

Authors:  Alicea Lieberman; Ayelet Gneezy; Emily Berry; Stacie Miller; Mark Koch; Chul Ahn; Bijal A Balasubramanian; Keith E Argenbright; Samir Gupta
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-08-06       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.